{"nct_id":"NCT03558503","title":"A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2018-10-15","start_date_type":"ACTUAL","primary_completion_date":"2020-01-03","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-21","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["URGN"]}